Julie Guillermet‐Guibert

Author

Also Known As

Denais, Celine, Guillermet, Julie, Guillermet-Guibert, Julie, J GUILLERMET, J Guillermet, J Guillermet-Guibert, J, Guillermet-Guibert, J. Guillermet, J. Guillermet-Guibert, JULIE GUILLERMET

179

Publications

5.2K

Citations

H-Index

Concepts

All Affiliations

Inserm Centre National de la Recherche Scientifique Université Toulouse III - Paul Sabatier Centre de Recherche en Cancérologie de Toulouse Université Fédérale de Toulouse Midi-Pyrénées

About

Julie Guillermet‐Guibert is an author at Inserm specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	12	1.4K
2	Engineering	2	2	133
3	Biomedical Engineering	2	2	133
4	Health Sciences	1	1	33
5	Public Health	1	1	50

Julie Guillermet‐Guibert

Publications

2.6K

Citations

H-Index

Page 1

	Year	Citations
Angiogenesis selectively requires the p110α isoform of PI3K to control endothelial cell migration Mariona Graupera, Julie Guillermet‐Guibert, Lazaros C. Foukas, Nature Developmental BiologyAngiogenesisSignaling PathwayP110α IsoformEndothelial Cell Migration	2008	510
The p110β isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110γ Julie Guillermet‐Guibert, Katja Björklöf, Ashreena Salpekar, Proceedings of the National Academy of Sciences P110gamma ExpressionCellular PhysiologySignaling PathwayReceptor Tyrosine KinaseGpcr-linked Pi3k	2008	340
Dominant Role of the p110β Isoform of PI3K over p110α in Energy Homeostasis Regulation by POMC and AgRP Neurons Hind Al‐Qassab, Mark A. Smith, Elaine E. Irvine, Cell Metabolism	2009	153
Hypoxia Induces VEGF-C Expression in Metastatic Tumor Cells via a HIF-1α-Independent Translation-Mediated Mechanism Florent Morfoisse, Anna Kuchnio, Clément Frainay, Cell Reports	2014	151
Deletion of the p110β isoform of phosphoinositide 3-kinase in platelets reveals its central role in Akt activation and thrombus formation in vitro and in vivo Valérie Martin, Julie Guillermet‐Guibert, Gaëtan Chicanne, Blood	2010	136
Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug Julie Guillermet‐Guibert, Lise Davenne, Dmitri Pchejetski, Molecular Cancer Therapeutics	2009	136
Pancreatic cell plasticity and cancer initiation induced by oncogenic Kras is completely dependent on wild-type PI 3-kinase p110α Romain Baer, Célia Cintas, Marlène Dufresne, Genes & Development PathologyCancer InitiationPi3k P110αCancer BiologyTumor Biology	2014	126
Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis Julie Guillermet‐Guibert, Nathalie Saint‐Laurent, Philippe Rochaix, Proceedings of the National Academy of Sciences	2002	124
Laser-assisted 3D bioprinting of exocrine pancreas spheroid models for cancer initiation study D. Hakobyan, Chantal Médina, Nathalie Dusserre, Biofabrication EngineeringCancer Initiation StudyBiofabricationBiomedical EngineeringTumor Biology	2020	119
Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway Corinne Bousquet, Julie Guillermet‐Guibert, Nathalie Saint‐Laurent, The EMBO Journal Signal TransductionSignaling PathwayG Protein-coupled ReceptorReceptor Tyrosine KinaseDirect Binding	2006	84

Page 1